G. Stewart

发表

A Randomized Trial Comparing Hormone Replacement Therapy (HRT) and HRT Plus Calcitriol in the Treatment of Postmenopausal Osteoporosis with Vertebral Fractures: Benefit of the Combination on Total Body and Hip Density

P. J. Drury, K. Jamrozik, R. Prince, 2003, Calcified Tissue International.

A randomized clinical trial comparing oral alendronate and intravenous pamidronate for the treatment of Paget's disease of bone.

P. J. Drury, S. Vasikaran, J. Walsh, 2004, Bone.

Comparison of biochemical markers of bone turnover in paget disease treated with pamidronate and a proposed model for the relationships between measurements of the different forms of pyridinoline cross‐links

R. Prince, D. Pearce, B. Stuckey, 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Prevention of appendicular bone loss in Paget's disease following treatment with intravenous pamidronate disodium.

R. Prince, B. Stuckey, R. Price, 1999, Bone.

Rapid, divergent changes in spinal and forearm bone density following short‐term intravenous treatment of paget's disease with pamidronate disodium

R. Prince, B. Stuckey, G. Nicholson, 1993 .

Calcium Absorption in Postmenopausal Osteoporosis: Benefit of HRT Plus Calcitriol, but not HRT Alone, in both Malabsorbers and Normal Absorbers

K. Jamrozik, R. Prince, B. Stuckey, 2000, Osteoporosis International.

Clinical, biochemical, hematologic, and radiographic responses in Paget's disease following intravenous pamidronate disodium: a 2-year study.

R. Prince, B. Stuckey, G. Nicholson, 1996, Bone.

Rapid, divergent changes in spinal and forearm bone density following short-term intravenous treatment of Paget's disease with pamidronate disodium.

R. Prince, B. Stuckey, G. Nicholson, 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Bone density changes in Paget's disease 2 years after iv pamidronate: profound, sustained increases in pagetic bone with severity-related loss in forearm nonpagetic cortical bone.

R. Prince, B. Stuckey, G. Nicholson, 2003, Bone.

Iritis following intravenous pamidronate.

I. Constable, R. Prince, B. Stuckey, 1996, Australian and New Zealand journal of medicine.

A Randomized Trial of Sodium Fluoride (60 mg) ± Estrogen in Postmenopausal Osteoporotic Vertebral Fractures: Increased Vertebral Fractures and Peripheral Bone Loss with Sodium Fluoride; Concurrent Estrogen Prevents Peripheral Loss, But Not Vertebral Fractures

K. Jamrozik, R. Prince, B. Stuckey, 2002, Osteoporosis International.

A randomized treatment trial of intravenous pamidronate and oral alendronate in Paget’s disease: early results ☆

R. Prince, B. Stuckey, R. Price, 1999 .

Paget's disease: Acquired resistance to one aminobisphosphonate with retained response to another

S. Vasikaran, R. Prince, R. Price, 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.